Masimo Corp share price today

(MASI)

Masimo Corp share price is $169.79 & ₹14,379.52 as on 7 Dec 2024, 2.30 'hrs' IST

$169.79

▲

0.4

(0.24%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Masimo Corp share price in Dollar and Rupees. Guide to invest in Masimo Corp from India. Also see the sentimental analysis on Indian investors investing in Masimo Corp. Get details on the Indian mutual funds that are investing in Masimo Corp. Get Analyst recommendations and forecasts along with all the Masimo Corp's financials.

Masimo Corp share price movements

$168.98
$172.65
$169.79
0.48%
Downside
Day's Volatility :2.13%
Upside
1.66%
$101.35
$178.28
$169.79
40.31%
Downside
52 Weeks Volatility :43.15%
Upside
4.76%

Masimo Corp Returns

Period	Masimo Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	52.11%	-5.7%	0.0%
6 Months	33.21%	-0.9%	0.0%
1 Year	65.18%	10.0%	0.0%
3 Years	-38.8%	9.3%	-21.5%

Masimo Corp Key Statistics

in dollars & INR

Previous Close	$169.39
Open	$169.37
Today's High	$172.65
Today's Low	$168.98
Market Capitalization	$9.2B
Today's Volume	$240.4K
52 Week High	$178.275
52 Week Low	$101.35
Revenue TTM	$2.0B
EBITDA	$199.0M
Earnings Per Share (EPS)	$1.42
PE Ratio	119.29
Profit Margin	3.85%
Quarterly Earnings Growth YOY	-0.1%
Return On Equity TTM	5.74%

How to invest in Masimo Corp from India?

It is very easy for Indian residents to invest directly in Masimo Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Masimo Corp stock in both rupees (INR) and dollars (USD). Search for Masimo Corp or MASI on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Masimo Corp or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Masimo Corp shares which would translate to 0.005 fractional shares of Masimo Corp as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Masimo Corp

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for Masimo Corp on INDmoney from India has grown in the last 30 days as on Dec 8, 2024. 0% more investors are searching Masimo Corp in the last 30 days versus the previous period.

Global Institutional Holdings in Masimo Corp

BlackRock Inc
17.47%
FMR Inc
12.62%
Politan Capital Management LP
8.81%
Vanguard Group Inc
8.44%
T. Rowe Price Investment Management,Inc.
2.85%
RTW INVESTMENTS, LLC
2.73%

Analyst Recommendation on Masimo Corp

Buy

66%Buy

33%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Masimo Corp(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Masimo Corp

What analysts predicted

Downside of 0.46%

Current:

$169.79

Target:

$169.02

Insights on Masimo Corp

Increasing Revenue
Revenue is up for the last 3 quarters, 492.8M → 504.6M (in $), with an average increase of 1.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 33.9M → 9.8M (in $), with an average decrease of 32.8% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 64.5% return, outperforming this stock by 5.4%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 118.7% return, outperforming this stock by 158.8%

Masimo Corp Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$858.3M	↑ 7.54%
Net Income	$193.5M	↑ 47.05%
Net Profit Margin	22.55%	↑ 6.06%

	FY19	Y/Y Change
Revenue	$937.8M	↑ 9.27%
Net Income	$196.2M	↑ 1.38%
Net Profit Margin	20.92%	↓ 1.63%

	FY20	Y/Y Change
Revenue	$1.1B	↑ 21.96%
Net Income	$240.3M	↑ 22.47%
Net Profit Margin	21.01%	↑ 0.09%

	FY21	Y/Y Change
Revenue	$1.2B	↑ 8.34%
Net Income	$229.6M	↓ 4.45%
Net Profit Margin	18.53%	↓ 2.48%

	FY22	Y/Y Change
Revenue	$2.0B	↑ 64.29%
Net Income	$143.5M	↓ 37.5%
Net Profit Margin	7.05%	↓ 11.48%

	FY23	Y/Y Change
Revenue	$2.0B	↑ 0.6%
Net Income	$81.5M	↓ 43.21%
Net Profit Margin	3.98%	↓ 3.07%

	Q2 FY23	Q/Q Change
Revenue	$455.3M	↓ 19.42%
Net Income	$15.7M	↓ 26.29%
Net Profit Margin	3.45%	↓ 0.32%

	Q3 FY23	Q/Q Change
Revenue	$478.9M	↑ 5.18%
Net Income	$10.6M	↓ 32.48%
Net Profit Margin	2.21%	↓ 1.24%

	Q4 FY23	Q/Q Change
Revenue	$548.9M	↑ 14.62%
Net Income	$33.9M	↑ 219.81%
Net Profit Margin	6.18%	↑ 3.97%

	Q1 FY24	Q/Q Change
Revenue	$492.8M	↓ 10.22%
Net Income	$18.9M	↓ 44.25%
Net Profit Margin	3.84%	↓ 2.34%

	Q2 FY24	Q/Q Change
Revenue	$496.3M	↑ 0.71%
Net Income	$16.0M	↓ 15.34%
Net Profit Margin	3.22%	↓ 0.62%

	Q3 FY24	Q/Q Change
Revenue	$504.6M	↑ 1.67%
Net Income	$9.8M	↓ 38.75%
Net Profit Margin	1.94%	↓ 1.28%

	FY18	Y/Y Change
Total Assets	$1.2B	↑ 26.87%
Total Liabilities	$185.8M	↓ 8.64%

	FY19	Y/Y Change
Total Assets	$1.4B	↑ 20.9%
Total Liabilities	$228.3M	↑ 22.88%

	FY20	Y/Y Change
Total Assets	$1.7B	↑ 22.66%
Total Liabilities	$304.9M	↑ 33.58%

	FY21	Y/Y Change
Total Assets	$1.9B	↑ 10.19%
Total Liabilities	$336.8M	↑ 10.45%

	FY22	Y/Y Change
Total Assets	$3.2B	↑ 70.14%
Total Liabilities	$1.9B	↑ 455.79%

	FY23	Y/Y Change
Total Assets	$3.0B	↓ 5.27%
Total Liabilities	$1.7B	↓ 10.42%

	Q2 FY23	Q/Q Change
Total Assets	$3.0B	↓ 3.35%
Total Liabilities	$1.7B	↓ 4.61%

	Q3 FY23	Q/Q Change
Total Assets	$3.0B	↓ 0.51%
Total Liabilities	$1.7B	↑ 1.02%

	Q4 FY23	Q/Q Change
Total Assets	$3.0B	↑ 1.52%
Total Liabilities	$1.7B	↓ 2.53%

	Q1 FY24	Q/Q Change
Total Assets	$3.0B	↓ 2.76%
Total Liabilities	$1.6B	↓ 5.02%

	Q2 FY24	Q/Q Change
Total Assets	$2.9B	↓ 2.16%
Total Liabilities	$1.5B	↓ 4.23%

	Q3 FY24	Q/Q Change
Total Assets	$3.1B	↑ 6.7%
Total Liabilities	$1.6B	↑ 6.52%

	FY18	Y/Y Change
Operating Cash Flow	$239.5M	↑ 312.21%
Investing Cash Flow	$-26.2M	↓ 45.41%
Financing Cash Flow	$25.8M	↓ 723.01%

	FY19	Y/Y Change
Operating Cash Flow	$221.6M	↓ 7.47%
Investing Cash Flow	$-197.7M	↑ 655.89%
Financing Cash Flow	$-9.3M	↓ 136.23%

	FY20	Y/Y Change
Operating Cash Flow	$211.0M	↓ 4.82%
Investing Cash Flow	$-82.8M	↓ 58.12%
Financing Cash Flow	$-54.3M	↑ 481.51%

	FY21	Y/Y Change
Operating Cash Flow	$264.8M	↑ 25.5%
Investing Cash Flow	$-37.5M	↓ 54.67%
Financing Cash Flow	$-122.4M	↑ 125.39%

	FY22	Y/Y Change
Operating Cash Flow	$29.5M	↓ 88.86%
Investing Cash Flow	$-1.1B	↑ 2718.35%
Financing Cash Flow	$520.3M	↓ 525.07%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$23.6M	↑ 5800.0%
Investing Cash Flow	$-22.4M	↑ 101.8%
Financing Cash Flow	$-4.9M	↓ 86.08%

Masimo Corp Technicals Summary

Sell

Neutral

Buy

Masimo Corp is currently in a neutral trading position according to technical analysis indicators.

Masimo Corp Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Masimo Corp	4.3%	33.21%	65.18%	-38.8%	10.94%
Stryker Corporation	3.41%	9.85%	30.52%	46.79%	93.03%
Boston Scientific Corp.	4.2%	16.93%	63.83%	119.31%	105.7%
Edwards Lifesciences Corp.	10.01%	-15.88%	3.02%	-39.81%	-5.18%
Abbott Laboratories	0.25%	7.54%	8.82%	-12.78%	36.7%
Medtronic Plc	-4.52%	1.2%	5.54%	-25.41%	-24.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Masimo Corp	119.29	119.29	4.73	4.03	0.06	0.03	NA	27.33
Stryker Corporation	40.99	40.99	2.67	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.82	74.82	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.63	28.63	6.78	2.52	0.19	0.11	NA	16.18
Abbott Laboratories	35.24	35.24	2.25	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Masimo Corp	Buy	$9.2B	10.94%	119.29	3.85%
Stryker Corporation	Buy	$145.8B	93.03%	40.99	16.34%
Boston Scientific Corp.	Buy	$133.9B	105.7%	74.82	11.26%
Edwards Lifesciences Corp.	Buy	$42.7B	-5.18%	28.63	65.86%
Abbott Laboratories	Buy	$201.1B	36.7%	35.24	13.99%
Medtronic Plc	Buy	$110.6B	-24.23%	26.38	12.06%

About Masimo Corp

masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.

Organization	Masimo Corp
Employees	3800
CEO	Ms. Michelle M. Brennan
Industry	Health Technology

Management People of Masimo Corp

Name	Title
Ms. Michelle M. Brennan	Interim CEO & Director
Mr. Micah Young CPA	Executive VP & CFO
Mr. Bilal Muhsin	Chief Operating Officer
Mr. Thomas Samuel McClenahan J.D.	Executive VP, General Counsel & Corporate Secretary
Mr. Paul Hataishi	Senior VP & Chief Accounting Officer
Mr. Yongsam Lee	Executive VP & Chief Information Officer
Dr. Steven J. Barker	Chairman of Scientific Advisory Board & Chief Science Officer
Mr. Eli Kammerman	Vice President of Business Development & Investor Relations
Mr. Anand Sampath	Executive Vice President of Operations & Clinical Research
Mr. Blair Tripodi	Chief Operating Officer of Consumer Division

Important FAQs about investing in Masimo Corp from India :

What is Masimo Corp share price today?

Masimo Corp (MASI) share price today is $169.79.

Can Indians buy Masimo Corp shares?

Yes, Indians can invest in the Masimo Corp (MASI) from India.

With INDmoney, you can buy Masimo Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Masimo Corp at zero transaction cost.

How can I buy Masimo Corp shares from India?

It is very easy to buy Masimo Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Masimo Corp be purchased?

Yes, you can buy fractional shares of Masimo Corp with INDmoney app.

What are the documents required to start investing in Masimo Corp stocks?

To start investing in Masimo Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.